AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Met-Plus-G2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Bi-Cure Remedies

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Met-Plus-G2 Tablet SR

Duo-Diabetic SR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Duo-Diabetic SR should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by symptoms such as sweating, dizziness, headaches, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Met-Plus-G2 Tablet SR

The information is unavailable.

Uses of Met-Plus-G2 Tablet SR

Managing type 2 diabetes

Major Benefits of Met-Plus-G2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Met-Plus-G2 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication should be taken with a meal.

Common Side effects of Met-Plus-G2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Met-Plus-G2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Met-Plus-G2 Tablet SR. Ingest the tablet whole; do not crush, chew, or fracture it. Administer this medication with a meal.

How Met-Plus-G2 Tablet SR works:

Glimepiride and Metformin, combined as Met-Plus-G2 SR tablets, offer dual action against high blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Met-Plus-G2 SR tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Met-Plus-G2 SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Extended-release Met-Plus-G2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Met-Plus-G2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Met-Plus-G2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Met-Plus-G2 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver disease, initiate Met-Plus-G2 Tablet SR therapy at a reduced dosage; avoid use in cases of severe liver dysfunction.

What if you forget to take Met-Plus-G2 Tablet SR :

Should you forget a Met-Plus-G2 Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Met-Plus-G2 Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Met-Plus-G2 Tablet SR

Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medicine. Prevent access by children, pets, and others.
Indeed, Met-Plus-G2 Tablet SR can induce lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare adverse reaction to metformin poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Manifestations of lactic acidosis might encompass muscle aches or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Met-Plus-G2 Tablet SR and seek immediate medical attention.
Glimepiride and Metformin, combined as Met-Plus-G2 SR tablets, treat type 2 diabetes mellitus. This medication helps regulate blood sugar in adults when coupled with a healthy diet and physical activity. Glimepiride's action involves stimulating insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and enhances insulin responsiveness. This dual-drug formulation is unsuitable for managing type 1 diabetes.
Met-Plus-G2 SR tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Met-Plus-G2 Tablet SR use can indeed lead to Vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures proposed by some studies include annual supplemental Vitamin B12 intake.
Indeed, Met-Plus-G2 Tablet SR can lead to hypoglycemia, characterized by low blood glucose. Manifestations of this condition may encompass nausea, headache, irritability, increased hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. It's advisable to always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Combining Met-Plus-G2 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Met-Plus-G2 Tablet SR
94
MRP 115
18% off